Taiwan FDA registration f75edd6ab7eb426f9073271636c2dede
Amplatzer Trevisio Intravascular Delivery System
TW: 安普拉茲翠菲絲遞送導管系統
Taiwan·Risk Class 2·MD·Abbott Medical·Registered Apr 30, 2021 – Apr 30, 2026ExpiredRegistration details
- Analysis ID
- f75edd6ab7eb426f9073271636c2dede
- License Form
- Ministry of Health Medical Device Import No. 034511
- Customs Code
- DHA05603451103
Company information
- Manufacturer
- Abbott Medical
- Manufacturer Country
- United States
- Authorized Representative
- Abbott Medical Taiwan Co.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- E Cardiovascular devices
- Product Type (Level 2)
- E1250 Percutaneous catheter
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Apr 30, 2021
- Expiry Date
- Apr 30, 2026
About this record
Access comprehensive regulatory information for Amplatzer Trevisio Intravascular Delivery System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f75edd6ab7eb426f9073271636c2dede and manufactured by Abbott Medical. The authorized representative in Taiwan is Abbott Medical Taiwan Co..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices